• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对 1 号蛋白酶适应的 α1-抗胰蛋白酶变体抑制拉萨病毒糖蛋白的切割和多轮复制。

Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.

机构信息

Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.

出版信息

PLoS Negl Trop Dis. 2009 Jun 2;3(6):e446. doi: 10.1371/journal.pntd.0000446.

DOI:10.1371/journal.pntd.0000446
PMID:19488405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2685025/
Abstract

BACKGROUND

Proteolytic processing of the Lassa virus envelope glycoprotein precursor GP-C by the host proprotein convertase site 1 protease (S1P) is a prerequisite for the incorporation of the subunits GP-1 and GP-2 into viral particles and, hence, essential for infectivity and virus spread. Therefore, we tested in this study the concept of using S1P as a target to block efficient virus replication.

METHODOLOGY/PRINCIPAL FINDING: We demonstrate that stable cell lines inducibly expressing S1P-adapted alpha(1)-antitrypsin variants inhibit the proteolytic maturation of GP-C. Introduction of the S1P recognition motifs RRIL and RRLL into the reactive center loop of alpha(1)-antitrypsin resulted in abrogation of GP-C processing by endogenous S1P to a similar level observed in S1P-deficient cells. Moreover, S1P-specific alpha(1)-antitrypsins significantly inhibited replication and spread of a replication-competent recombinant vesicular stomatitis virus expressing the Lassa virus glycoprotein GP as well as authentic Lassa virus. Inhibition of viral replication correlated with the ability of the different alpha(1)-antitrypsin variants to inhibit the processing of the Lassa virus glycoprotein precursor.

CONCLUSIONS/SIGNIFICANCE: Our data suggest that glycoprotein cleavage by S1P is a promising target for the development of novel anti-arenaviral strategies.

摘要

背景

拉沙病毒包膜糖蛋白前体 GP-C 通过宿主蛋白转化酶位点 1 蛋白酶(S1P)的蛋白水解处理是将亚基 GP-1 和 GP-2 掺入病毒颗粒的先决条件,因此对于感染性和病毒传播至关重要。因此,我们在本研究中测试了将 S1P 作为靶标以阻断有效病毒复制的概念。

方法/主要发现:我们证明,稳定表达 S1P 适应的 α1-抗胰蛋白酶变体的细胞系可抑制 GP-C 的蛋白水解成熟。将 S1P 识别基序 RRIL 和 RRLL 引入 α1-抗胰蛋白酶的反应中心环中,导致内源性 S1P 对 GP-C 的处理被阻断,达到在 S1P 缺陷细胞中观察到的相似水平。此外,S1P 特异性 α1-抗胰蛋白酶显著抑制表达拉沙病毒糖蛋白 GP 的复制型重组水疱性口炎病毒以及真实拉沙病毒的复制和传播。病毒复制的抑制与不同 α1-抗胰蛋白酶变体抑制拉沙病毒糖蛋白前体的加工能力相关。

结论/意义:我们的数据表明,糖蛋白通过 S1P 的切割是开发新型抗沙粒病毒策略的有前途的靶标。

相似文献

1
Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.通过对 1 号蛋白酶适应的 α1-抗胰蛋白酶变体抑制拉萨病毒糖蛋白的切割和多轮复制。
PLoS Negl Trop Dis. 2009 Jun 2;3(6):e446. doi: 10.1371/journal.pntd.0000446.
2
Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.针对病毒糖蛋白前体的蛋白水解加工进行靶向处理是一种针对沙粒病毒的有前途的新型抗病毒策略。
J Virol. 2010 Jan;84(1):573-84. doi: 10.1128/JVI.01697-09.
3
Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.描述拉沙病毒糖蛋白寡聚化及胆固醇对病毒复制的影响。
J Virol. 2010 Jan;84(2):983-92. doi: 10.1128/JVI.02039-09. Epub 2009 Nov 4.
4
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.拉沙病毒糖蛋白前体GP-C由枯草杆菌蛋白酶SKI-1/S1P进行蛋白水解加工。
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12701-5. doi: 10.1073/pnas.221447598. Epub 2001 Oct 16.
5
Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein.转化酶SKI-1/S1P前体蛋白的基于蛋白质的抑制剂的开发:SREBP-2、ATF6和一种病毒糖蛋白的加工
J Biol Chem. 2004 Apr 23;279(17):17338-47. doi: 10.1074/jbc.M313764200. Epub 2004 Feb 16.
6
Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.细胞蛋白酶 1 作用位点小分子抑制剂抗沙粒病毒糖蛋白加工的活性。
J Virol. 2011 Jan;85(2):795-803. doi: 10.1128/JVI.02019-10. Epub 2010 Nov 10.
7
Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease.沙粒病毒包膜糖蛋白前体的枯草杆菌蛋白酶 kexin 同工酶-1/位点-1 蛋白酶加工的分子特征。
J Virol. 2012 May;86(9):4935-46. doi: 10.1128/JVI.00024-12. Epub 2012 Feb 22.
8
The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain.蛋白水解加工和稳定信号肽在旧大陆沙粒病毒包膜糖蛋白胞外结构域表达中的作用。
Virology. 2013 Feb 5;436(1):127-33. doi: 10.1016/j.virol.2012.10.038. Epub 2012 Dec 4.
9
The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C.单个N-聚糖在拉沙病毒糖蛋白GP-C的蛋白水解加工和细胞表面转运中的作用
Virol J. 2006 May 31;3:41. doi: 10.1186/1743-422X-3-41.
10
Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity.拉沙病毒包膜糖蛋白GP-2的两个N端疏水区域的氨基酸对于pH依赖性膜融合和感染性至关重要。
J Gen Virol. 2007 Aug;88(Pt 8):2320-2328. doi: 10.1099/vir.0.82950-0.

引用本文的文献

1
Lassa Virus Infection of Primary Human Airway Epithelial Cells.拉沙病毒对原代人呼吸道上皮细胞的感染。
Viruses. 2025 Apr 22;17(5):592. doi: 10.3390/v17050592.
2
Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors.细胞蛋白酶抑制剂对病毒糖蛋白成熟的限制。
Viruses. 2024 Feb 22;16(3):332. doi: 10.3390/v16030332.
3
How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?包膜病毒如何利用分泌型蛋白前体转化酶来调节感染性和传播?

本文引用的文献

1
Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.在沙粒病毒出血热模型中对晚期疾病的治疗:T-705的疗效及毒性降低表明其可作为利巴韦林的替代药物。
PLoS One. 2008;3(11):e3725. doi: 10.1371/journal.pone.0003725. Epub 2008 Nov 14.
2
A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.一种适用于高通量筛选沙粒病毒出芽抑制剂的基于细胞的荧光素酶检测方法。
Virology. 2008 Dec 5;382(1):107-14. doi: 10.1016/j.virol.2008.09.008. Epub 2008 Oct 16.
3
Unknown disease in South Africa identified as arenavirus infection.
Viruses. 2021 Jun 25;13(7):1229. doi: 10.3390/v13071229.
4
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.表达拉沙病毒包膜表面糖蛋白天然样形式的佐剂配方病毒样颗粒具有免疫原性,并诱导产生具有广泛中和活性的抗体。
NPJ Vaccines. 2020 Aug 4;5(1):71. doi: 10.1038/s41541-020-00219-x. eCollection 2020.
5
A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease.一种用于表征沙粒病毒包膜糖蛋白经枯草杆菌蛋白酶/kexin 同工酶 1/1 位点蛋白酶切割的分子传感器。
J Virol. 2015 Oct 28;90(2):705-14. doi: 10.1128/JVI.01751-15. Print 2016 Jan 15.
6
Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P).旧世界和新世界沙粒病毒包膜糖蛋白被枯草杆菌蛋白酶 Kexin 同工酶 1(SKI-1)/位点 1 蛋白酶(S1P)的差异识别。
J Virol. 2013 Jun;87(11):6406-14. doi: 10.1128/JVI.00072-13. Epub 2013 Mar 27.
7
Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.针对沙粒病毒出血热的预防和治疗的毒力机制。
Antiviral Res. 2013 Feb;97(2):81-92. doi: 10.1016/j.antiviral.2012.12.003. Epub 2012 Dec 20.
8
Envelope glycoprotein of arenaviruses.沙粒病毒属的包膜糖蛋白。
Viruses. 2012 Oct 17;4(10):2162-81. doi: 10.3390/v4102162.
9
Molecular mechanism of arenavirus assembly and budding.沙粒病毒组装和出芽的分子机制。
Viruses. 2012 Oct 10;4(10):2049-79. doi: 10.3390/v4102049.
10
Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease.沙粒病毒包膜糖蛋白前体的枯草杆菌蛋白酶 kexin 同工酶-1/位点-1 蛋白酶加工的分子特征。
J Virol. 2012 May;86(9):4935-46. doi: 10.1128/JVI.00024-12. Epub 2012 Feb 22.
南非的未知疾病被确定为沙粒病毒感染。
Euro Surveill. 2008 Oct 16;13(42):19008.
4
Reverse genetics approaches to combat pathogenic arenaviruses.对抗致病性沙粒病毒的反向遗传学方法。
Antiviral Res. 2008 Dec;80(3):239-50. doi: 10.1016/j.antiviral.2008.08.002. Epub 2008 Sep 7.
5
Identification of a broad-spectrum arenavirus entry inhibitor.一种广谱沙粒病毒进入抑制剂的鉴定。
J Virol. 2008 Nov;82(21):10768-75. doi: 10.1128/JVI.00941-08. Epub 2008 Aug 20.
6
Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses.作为抗出血热病毒的抗病毒剂的N-取代吖啶酮的合成与评价
Antivir Chem Chemother. 2008;19(1):41-7. doi: 10.1177/095632020801900106.
7
Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals.对1型蛋白酶活性的药理学抑制可抑制固醇调节元件结合蛋白的加工,并降低培养细胞和实验动物中脂肪生成酶基因的表达及脂质合成。
J Pharmacol Exp Ther. 2008 Sep;326(3):801-8. doi: 10.1124/jpet.108.139626. Epub 2008 Jun 24.
8
Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.出血热沙粒病毒独特的小分子进入抑制剂。
J Biol Chem. 2008 Jul 4;283(27):18734-42. doi: 10.1074/jbc.M802089200. Epub 2008 May 12.
9
Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro.脱氢表雄酮、表雄酮及合成衍生物在体外可抑制胡宁病毒复制。
Virus Res. 2008 Aug;135(2):203-12. doi: 10.1016/j.virusres.2008.03.014. Epub 2008 May 6.
10
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia.查帕雷病毒,一种从玻利维亚一例致命出血热病例中分离出的新发现沙粒病毒。
PLoS Pathog. 2008 Apr 18;4(4):e1000047. doi: 10.1371/journal.ppat.1000047.